Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 751 AL 765

Natural Bioactive Compounds from Macroalgae and Microalgae for the Treatment of Alzheimer's Disease: A Review

Lee JY, Wong CY, Koh RY, Lim CL, Kok YY, Chye SM.

Yale J Biol Med. 2024 Jun 28;97(2):205-224. doi: 10.59249/JNKB9714. eCollection 2024 Jun.

Delineation of the role of G6PD in Alzheimer's disease and potential enhancement through microfluidic and nanoparticle approaches

Sharallah OA, Poddar NK, Alwadan OA.

Ageing Res Rev. 2024 Aug;99:102394. doi: 10.1016/j.arr.2024.102394. Epub 2024 Jun 29.

An insight into the concept of neuroinflammation and neurodegeneration in Alzheimer's disease: targeting molecular approach Nrf2, NF-κB, and CREB

Bhardwaj S, Grewal AK, Singh S, Dhankar V, Jindal A.

Inflammopharmacology. 2024 Oct;32(5):2943-2960. doi: 10.1007/s10787-024-01502-2. Epub 2024 Jun 29.

APP dyshomeostasis in the pathogenesis of Alzheimer's disease: implications for current drug targets

Sirisi S, Sánchez-Aced É, Belbin O, Lleó A.

Alzheimers Res Ther. 2024 Jun 29;16(1):144. doi: 10.1186/s13195-024-01504-w.

Neolignans in Magnolia officinalis as natural anti-Alzheimer's disease agents: A systematic review

Li N, Liang Y, Zhang L, Xu C, Wang L.

Ageing Res Rev. 2024 Aug;99:102398. doi: 10.1016/j.arr.2024.102398. Epub 2024 Jun 30.

Exploring the therapeutic potential of steroidal alkaloids in managing Alzheimer's disease

Pandey PP, Kumar MS.

Steroids. 2024 Sep;209:109468. doi: 10.1016/j.steroids.2024.109468. Epub 2024 Jul 2.

Unique Properties of Synaptosomes and Prospects for Their Use for the Treatment of Alzheimer's Disease

Dashkova AS, Kovalev VI, Chaplygina AV, Zhdanova DY, Bobkova NV.

Biochemistry (Mosc). 2024 Jun;89(6):1031-1044. doi: 10.1134/S0006297924060051.

Comprehensive Overview of Alzheimer's Disease: Etiological Insights and Degradation Strategies

Singh MK, Shin Y, Ju S, Han S, Kim SS, Kang I.

Int J Mol Sci. 2024 Jun 24;25(13):6901. doi: 10.3390/ijms25136901.

Current View on PPAR-α and Its Relation to Neurosteroids in Alzheimer's Disease and Other Neuropsychiatric Disorders: Promising Targets in a Therapeutic Strategy

Żulińska S, Strosznajder AK, Strosznajder JB.

Int J Mol Sci. 2024 Jun 28;25(13):7106. doi: 10.3390/ijms25137106.

Novel Leptin-Based Therapeutic Strategies to Limit Synaptic Dysfunction in Alzheimer's Disease

Harvey J.

Int J Mol Sci. 2024 Jul 4;25(13):7352. doi: 10.3390/ijms25137352.

Chiral pyrrolidines as multipotent agents in Alzheimer and neurodegenerative diseases

Carrieri A, Barbarossa A, de Candia M, Samarelli F, Damiano Altomare C, Czarnota-Łydka K, Sudoł-Tałaj S, Latacz G, Handzlik J, Brunetti L, Piemontese L, Limongelli F, Lentini G, Carocci A.

Bioorg Med Chem. 2024 Aug 1;110:117829. doi: 10.1016/j.bmc.2024.117829. Epub 2024 Jul 3.

Phytochemicals targeting mitophagy: Therapeutic opportunities and prospects for treating Alzheimer's disease

Yang J, Zhao H, Qu S.

Biomed Pharmacother. 2024 Aug;177:117144. doi: 10.1016/j.biopha.2024.117144. Epub 2024 Jul 14.

Developing public-private R&D consortia to accelerate Alzheimer's disease drug development

West J, Olk P.

Drug Discov Today. 2024 Sep;29(9):104103. doi: 10.1016/j.drudis.2024.104103. Epub 2024 Jul 15.

Drugs targeting APOE4 that regulate beta-amyloid aggregation in the brain: Therapeutic potential for Alzheimer's disease

Poblano J, Castillo-Tobías I, Berlanga L, Tamayo-Ordoñez MC, Del Carmen Rodríguez-Salazar M, Silva-Belmares SY, Aguayo-Morales H, Cobos-Puc LE.

Basic Clin Pharmacol Toxicol. 2024 Sep;135(3):237-249. doi: 10.1111/bcpt.14055. Epub 2024 Jul 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias